Literature DB >> 18822684

Gliosarcomas in the elderly: analysis of 7 cases and clinico-pathological remarks.

Valerio di Norcia1, Manolo Piccirilli, Felice Giangaspero, Maurizio Salvati.   

Abstract

AIMS AND
BACKGROUND: Gliosarcomas are rare malignant primary brain tumors that usually affect the fifth or sixth decades of life. The purpose of this study was to describe our experience with such lesions in elderly patients and to establish their prognosis factors.
METHODS: Between 1993 and 2001, 7 patients over 60 years of age were treated at our institute for cerebral gliosarcomas. All patients underwent surgery for total or at least sub-total removal of a neoplastic mass.
RESULTS: Owing to poor clinical conditions (Karnofsky performance score = 40), one patient was not treated postoperatively. Remaining patients were treated with whole-brain radiotherapy, whereas concomitant chemotherapy (temozolomide) was administrated only to 4 patients. Histological examination showed the prevalence of sarcomatous aspects in 3 patients; the gliomatous aspect prevailed in 4 patients.
CONCLUSIONS: Sarcomatous aspects and multimodality treatment (surgery, radiotherapy and chemotherapy) were associated with a better prognosis and showed in these elderly patients a trend similar to that of young people.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18822684     DOI: 10.1177/030089160809400409

Source DB:  PubMed          Journal:  Tumori        ISSN: 0300-8916


  8 in total

1.  Gliosarcoma: A rare primary CNS tumor. Presentation of two cases.

Authors:  José Pardo; Mauricio Murcia; Felip García; Arnaldo Alvarado
Journal:  Rep Pract Oncol Radiother       Date:  2010-07-07

2.  Gliosarcoma: a clinical and radiological analysis of 48 cases.

Authors:  Xiaoping Yi; Hang Cao; Haiyun Tang; Guanghui Gong; Zhongliang Hu; Weihua Liao; Lunquan Sun; Bihong T Chen; Xuejun Li
Journal:  Eur Radiol       Date:  2018-06-12       Impact factor: 5.315

3.  O6-methylguanine DNA methyltransferase status determined by promoter methylation and immunohistochemistry in gliosarcoma and their clinical implications.

Authors:  Shin-Hyuk Kang; Kyung-Jae Park; Chae-Yong Kim; Mi Ok Yu; Chul-Kee Park; Sung-Hye Park; Yong-Gu Chung
Journal:  J Neurooncol       Date:  2010-06-17       Impact factor: 4.130

4.  Brain cancer prognosis: independent validation of a clinical bioinformatics approach.

Authors:  Raffaele Fronza; Michele Tramonti; William R Atchley; Christine Nardini
Journal:  J Clin Bioinforma       Date:  2012-02-01

5.  Impact of changing trends of treatment on outcome of cerebral gliosarcoma: A tertiary care centre experience.

Authors:  Narendra Kumar; Tapesh Bhattacharyya; Karan Chanchalani; Praveen Shalunke; B D Radotra; Budhi Singh Yadav
Journal:  South Asian J Cancer       Date:  2015 Jan-Mar

6.  Adjuvant Radiation Therapy and Temozolomide in Gliosarcoma: Is It Enough? Case Series of Seven Patients.

Authors:  Himanshu Srivastava; Abhinav Dewan; Surender Kumar Sharma; Preety Negi; Ajay Kumar Dewan; Sunil Pasricha; Krati Mehrotra
Journal:  Asian J Neurosurg       Date:  2018 Apr-Jun

7.  Gliosarcoma in Young Adults: A Rare Variant of Glioblastoma.

Authors:  Neha Kakkar; Jaspreet Kaur; Gunjesh Kumar Singh; Pragya Singh; Fouzia Siraj; Ajay Gupta
Journal:  World J Oncol       Date:  2017-05-04

8.  Gliosarcoma: A rare variant of glioblastoma multiforme in paediatric patient: Case report and review of literature.

Authors:  Ugan Singh Meena; Sumit Sharma; Sanjeev Chopra; Shashi Kant Jain
Journal:  World J Clin Cases       Date:  2016-09-16       Impact factor: 1.337

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.